Tschöp et al. managed LEP replacement with intra-peritoneal injection, intra-cerebro-ventricular or peripheral mini-pumps (subcutaneous), while Shapiro et al. used osmotic pumps implanted into the abdominal cavity, which might not be the best choice if the model of sepsis is peritoneal. The gene discussed is LEP; the disease is Sepsis.